(2) AUTHORIZATION
OF
APPROPRIATIONS.—
There is authorized to be appropriated to carry out 
this subsection $1,500,000 for each of fiscal years 
2007 through 2011. 
(r) REQUIREMENT
TO
SUBMIT
NATIONAL
SYN-
THETIC DRUGS ACTION STRATEGY.—Not later than 120 
days after the date of the enactment of this Act, the Direc-
tor of National Drug Control Policy shall submit to Con-
gress the National Synthetic Drugs Action Strategy out-
lined in the National Synthetic Drugs Action Plan sub-
mitted by the Director in October 2004. 
(s) REQUIREMENT
FOR STUDY
OF STATE PRE-
CURSOR CHEMICAL CONTROL LAWS.—
(1) STUDY.—The Director of National Drug 
Control Policy shall conduct a study of State laws 
with respect to precursor chemical controls. 
(2) REPORT.—Not later than six months after 
the date of the enactment of this Act, the Director 
of National Drug Control Policy shall submit a re-
port to Congress on the results of the study under 
paragraph (1), including—
(A) a comparison of the State laws studied 
and the effectiveness of each such law; and 
(B) a list of best practices observed with 
respect to such laws.
(t) REQUIREMENT FOR STUDY OF DRUG ENDAN-
GERED CHILDREN PROGRAMS.—
(1) STUDY.—The Director of National Drug 
Control Policy shall conduct a study of methamphet-
amine-related activities that are conducted by dif-
ferent Drug Endangered Children programs admin-
istered by States. 
(2) REPORT.—Not later than six months after 
the date of the enactment of this Act, the Director 
of National Drug Control Policy shall submit to 
Congress a report on the results of the study under 
paragraph (1). Such report shall include—
(A) an analysis of the best practices of the 
activities studied; and 
(B) recommendations for establishing a 
national policy to address drug endangered chil-
dren, based on the Drug Endangered Children 
programs administered by States. 
(3) DEFINITIONS.—In this subsection—
(A) the term ‘‘methamphetamine-related 
activity’’ means any activity related to the pro-
duction, use, or effects of methamphetamine; 
and 
(B) the term ‘‘drug endangered children’’ 
means children whose physical, mental, or emo-
tional health are at risk because of the produc-
tion, use, or effects of methamphetamine by an-
other person. 
(u) REQUIREMENT FOR METHAMPHETAMINE STRAT-
EGY.—
(1) IN GENERAL.—Not later than 90 days after 
the date of the enactment of this Act, the Director 
of the Office of National Drug Control Policy shall 
submit to Congress a comprehensive strategy that 
addresses the increased threat from methamphet-
amine. 
(2) MATTERS COVERED.—The strategy shall in-
clude—
(A) interdiction and precursor chemical 
controls; 
(B) demand reduction and treatment; 
(C) alternative development programs; 
(D) efforts to prevent the diversion of pre-
cursor chemicals on an international level; and 
(E) an assessment of the specific level of 
funding and resources necessary to significantly 
to reduce the production and trafficking of 
methamphetamine. 
(3) TREATMENT OF CLASSIFIED OR LAW EN-
FORCEMENT
SENSITIVE
INFORMATION.—Any con-
tent of the strategy that involves information classi-
fied under criteria established by an Executive order, 
or whose public disclosure, as determined by the Di-
rector or the head of any relevant Federal agency, 
would be detrimental to the law enforcement or na-
tional security activities of any Federal, foreign, or 
international agency, shall be presented to Congress 
separately from the rest of the strategy. 
SEC. 7. AMENDMENTS RELATING TO COORDINATION WITH 
OTHER AGENCIES. 
Section 705 (21 U.S.C. 1704) is amended—
(1) 
in 
subsection 
(a)(1)(A), 
by 
striking 
‘‘abuse’’; 
(2) in subsection (a)(2)(A), by striking ‘‘Direc-
tor of Central Intelligence’’ and inserting ‘‘Director 
of National Intelligence’’; 
(3) in subsection (a)(2)(B), by striking ‘‘Direc-
tor of Central Intelligence’’ and inserting ‘‘Director 
of National Intelligence and the Director of the Cen-
tral Intelligence Agency’’; 
(4) by amending paragraph (3) of subsection 
(a) to read as follows: 
‘‘(3) REQUIRED REPORTS.—
‘‘(A) SECRETARIES OF THE INTERIOR AND 
AGRICULTURE.—The Secretaries of Agriculture
and Interior shall, by July 1 of each year, joint-
ly submit to the Director, the appropriate con-
gressional committees, the Committee on Agri-
culture and the Committee on Resources of the 
House of Representatives, and the Committee 
on Agriculture and the Committee on Energy 
and Natural Resources of the Senate, an as-
sessment of the quantity of illegal drug cultiva-
tion and manufacturing in the United States on 
lands owned or under the jurisdiction of the 
Federal Government for the preceding year. 
‘‘(B) ATTORNEY GENERAL.—The Attorney 
General shall, by July 1 of each year, submit to 
the Director and the appropriate congressional 
committees information for the preceding year 
regarding the number and type of—
‘‘(i) arrests for drug violations; 
‘‘(ii) prosecutions for drug violations 
by United States Attorneys; and 
‘‘(iii) seizures of drugs by each com-
ponent of the Department of Justice seiz-
ing drugs, as well as statistical information 
on the geographic areas of such seizures. 
‘‘(C) SECRETARY
OF
HOMELAND
SECU-
RITY.—The Secretary of Homeland Security
shall, by July 1 of each year, submit to the Di-
rector, the appropriate congressional commit-
tees, and the Committee on Homeland Security 
of the House of Representatives, and the Com-
mittee on Homeland Security and Govern-
mental Affairs of the Senate, information for 
the preceding year regarding—
‘‘(i) the number and type of seizures 
of drugs by each component of the Depart-
ment of Homeland Security seizing drugs, 
as well as statistical information on the ge-
ographic areas of such seizures; and 
‘‘(ii) the number of air and maritime 
patrol hours undertaken by each compo-
nent of that Department primarily dedi-
cated to drug supply reduction missions. 
‘‘(D) SECRETARY OF DEFENSE.—The Sec-
retary of Defense shall, by July 1 of each year, 
submit to the Director, the appropriate congres-
sional committees, the Committee on Armed 
Services of the House of Representatives, and 
the Committee on Armed Services of the Sen-
ate, information for the preceding year regard-
ing the number of air and maritime patrol 
hours primarily dedicated to drug supply reduc-
tion missions undertaken by each component of 
the Department of Defense.’’; 
(5) in subsection (b)(2)(B), by striking ‘‘Pro-
gram.’’ and inserting ‘‘Strategy.’’; and 
(6) in subsection (c), by striking ‘‘in’’ and in-
serting ‘‘on’’. 
SEC. 8. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
Section 706 (21 U.S.C. 1705) is amended to read as 
follows: 
‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 
AND ASSESSMENT OF NATIONAL DRUG CON-
TROL STRATEGY. 
‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL-
OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL 
STRATEGY.—
‘‘(1) IN GENERAL.—Not later than February 1 
of each year, the President shall submit to Congress 
a National Drug Control Strategy, which shall set 
forth a comprehensive plan for reducing illicit drug 
use and the consequences of illicit drug use in the 
United States by reducing the demand for illegal 
drugs, limiting the availability of illegal drugs, and
conducting law enforcement activities with respect to 
illegal drugs. 
‘‘(2) CONTENTS.—
‘‘(A) IN
GENERAL.—The National Drug 
Control Strategy submitted under paragraph 
(1) shall include the following: 
‘‘(i) Comprehensive, research-based, 
long-range, and quantifiable goals for re-
ducing illicit drug use and the con-
sequences of illicit drug use in the United 
States. 
‘‘(ii) Annual quantifiable objectives for 
demand reduction, supply reduction, and 
law enforcement activities, specific targets 
to accomplish long-range quantifiable re-
duction in illicit drug use as determined by 
the Director, and specific measurements to 
evaluate progress toward the targets and 
strategic goals. 
‘‘(iii) A strategy to reduce the avail-
ability and purity of illegal drugs and the 
level of drug-related crime in the United 
States. 
‘‘(iv) An assessment of Federal effec-
tiveness in achieving the National Drug
Control Strategy for the previous year, in-
cluding a specific evaluation of whether the 
objectives and targets for reducing illicit 
drug use for the previous year were met 
and reasons for the success or failure of 
the previous year’s Strategy. 
‘‘(v) A general review of the status of, 
and trends in, international, State, and 
local drug control activities to ensure that 
the United States pursues well-coordinated 
and effective drug control at all levels of 
government. 
‘‘(vi) A general review of the status 
of, and trends in, demand reduction activi-
ties by private sector entities and commu-
nity-based organizations, including faith-
based organizations, to determine their ef-
fectiveness and the extent of cooperation, 
coordination, and mutual support between 
such entities and organizations and Fed-
eral, State, and local government agencies. 
‘‘(vii) An assessment of current illicit 
drug use (including inhalants and steroids) 
and availability, impact of illicit drug use,
and treatment availability, which assess-
ment shall include—
‘‘(I) estimates of drug prevalence 
and frequency of use as measured by 
national, State, and local surveys of il-
licit drug use and by other special 
studies of nondependent and depend-
ent illicit drug use; 
‘‘(II) illicit drug use in the work-
place and the productivity lost by such 
use; and 
‘‘(III) 
illicit 
drug 
use 
by 
arrestees, probationers, and parolees. 
‘‘(viii) An assessment of the reduction 
of illicit drug availability, as measured 
by—
‘‘(I) the quantities of cocaine, 
heroin, marijuana, methamphetamine, 
ecstasy, and other drugs available for 
consumption in the United States; 
‘‘(II) the amount of marijuana, 
cocaine, heroin, methamphetamine, ec-
stasy, and precursor chemicals and 
other drugs entering the United 
States;
‘‘(III) the number of illicit drug 
manufacturing laboratories seized and 
destroyed and the number of hectares 
of marijuana, poppy, and coca cul-
tivated and destroyed domestically 
and in other countries; 
‘‘(IV) the number of metric tons 
of marijuana, heroin, cocaine, and 
methamphetamine seized and other 
drugs; and 
‘‘(V) changes in the price and 
purity of heroin, methamphetamine, 
and cocaine, changes in the price of 
ecstasy, 
and 
changes 
in 
tetrahydrocannabinol level of mari-
juana and other drugs. 
‘‘(ix) An assessment of the reduction 
of the consequences of illicit drug use and 
availability, which shall include—
‘‘(I) the burden illicit drug users 
place on hospital emergency depart-
ments in the United States, such as 
the quantity of illicit drug-related 
services provided;
‘‘(II) the annual national health 
care cost of illicit drug use; 
‘‘(III) the extent of illicit drug-
related crime and criminal activity; 
and 
‘‘(IV) the effect of illicit drug use 
on children of substance abusers. 
‘‘(x) A general review of the status of, 
and trends in, of drug treatment in the 
United States, by assessing—
‘‘(I) public and private treatment 
utilization; and 
‘‘(II) the number of illicit drug 
users the Director estimates meet di-
agnostic criteria for treatment. 
‘‘(xi) A review of the research agenda 
of the Counterdrug Technology Assessment 
Center to reduce the availability and abuse 
of drugs. 
‘‘(xii) A summary of the efforts made 
by Federal agencies to coordinate with pri-
vate sector entities to conduct private re-
search and development of medications to 
treat addiction by—
‘‘(I) screening chemicals for po-
tential therapeutic value; 
‘‘(II) developing promising com-
pounds; 
‘‘(III) conducting clinical trials; 
‘‘(IV) seeking, where appropriate, 
Food and Drug Administration ap-
proval for drugs to treat addiction; 
‘‘(V) marketing, where appro-
priate, the drug for the treatment of 
addiction; 
‘‘(VI) urging physicians, where 
appropriate, to use the drug in the 
treatment of addiction; and 
‘‘(VII) encouraging, where appro-
priate, insurance companies to reim-
burse the cost of the drug for the 
treatment of addiction. 
‘‘(xiii) Such additional statistical data 
and information as the Director considers 
appropriate to demonstrate and assess 
trends relating to illicit drug use, the ef-
fects and consequences of illicit drug use 
(including the effects on children of sub-
stance abusers), supply reduction, demand
reduction, drug-related law enforcement, 
and the implementation of the National 
Drug Control Strategy. 
‘‘(xiv) A supplement reviewing the ac-
tivities of each individual National Drug 
Control Program agency during the pre-
vious year with respect to the National 
Drug Control Strategy and the Director’s 
assessment of the progress of each Na-
tional Drug Control Program agency in 
meeting its responsibilities under the Na-
tional Drug Control Strategy. 
‘‘(B) 
CLASSIFIED
INFORMATION.—Any 
contents of the National Drug Control Strategy 
that involve information properly classified 
under criteria established by an Executive order 
shall be presented to Congress separately from 
the rest of the National Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for 
inclusion under subparagraph (A), the Director 
shall ensure—
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current 
trends against previously compiled data
and information where the Director be-
lieves such analysis enhances long-term as-
sessment of the National Drug Control 
Strategy; and 
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of 
drug treatment programs in the United 
States. 
‘‘(3) PROCESS FOR DEVELOPMENT AND SUB-
MISSION.—
‘‘(A) CONSULTATION.—In developing and 
effectively implementing the National Drug 
Control Strategy, the Director—
‘‘(i) shall consult with—
‘‘(I) the heads of the National 
Drug Control Program agencies; 
‘‘(II) Congress; 
‘‘(III) State and local officials; 
‘‘(IV) private citizens and organi-
zations, including community- and 
faith-based organizations, with experi-
ence and expertise in demand reduc-
tion;
‘‘(V) private citizens and organi-
zations with experience and expertise 
in supply reduction; 
‘‘(VI) private citizens and organi-
zations with experience and expertise 
in law enforcement; and 
‘‘(VII) appropriate representa-
tives of foreign governments; 
‘‘(ii) with the concurrence of the At-
torney General, may require the El Paso 
Intelligence Center to undertake specific 
tasks or projects to implement the Na-
tional Drug Control Strategy; 
‘‘(iii) with the concurrence of the Di-
rector of National Intelligence and the At-
torney General, may request that the Na-
tional Drug Intelligence Center undertake 
specific tasks or projects to implement the 
National Drug Control Strategy; and 
‘‘(iv) may make recommendations to 
the Secretary of Health and Human Serv-
ices on research that supports or advances 
the National Drug Control Strategy. 
‘‘(B) COMMITMENT
TO
SUPPORT
STRAT-
EGY.—In satisfying the requirements of sub-
paragraph (A)(i), the Director shall ensure, to 
the maximum extent possible, that State and 
local officials and relevant private organizations 
commit to support and take steps to achieve the 
goals and objectives of the National Drug Con-
trol Strategy. 
‘‘(C) RECOMMENDATIONS.—Recommenda-
tions under subparagraph (A)(iv) may include 
recommendations of research to be performed 
at the National Institutes of Health, including 
the National Institute on Drug Abuse, or any 
other appropriate agency within the Depart-
ment of Health and Human Services. 
‘‘(D) INCLUSION IN STRATEGY.—The Na-
tional Drug Control Strategy under this sub-
section shall include a list of each entity con-
sulted under subparagraph (A)(i). 
‘‘(4) SUBMISSION OF REVISED STRATEGY.—The 
President may submit to Congress a revised Na-
tional Drug Control Strategy that meets the require-
ments of this section—
‘‘(A) at any time, upon a determination by 
the President, in consultation with the Director, 
that the National Drug Control Strategy in ef-
fect is not sufficiently effective; or
‘‘(B) if a new President or Director takes 
office. 
‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not 
later than February 1 of each year, the Director shall sub-
mit to Congress, as part of the National Drug Control 
Strategy, a description of a national drug control perform-
ance measurement system that—
‘‘(1) develops 2-year and 5-year performance 
measures and targets for each National Drug Con-
trol Strategy goal and objective established for re-
ducing drug use, drug availability, and the con-
sequences of drug use; 
‘‘(2) describes the sources of information and 
data that will be used for each performance measure 
incorporated into the performance measurement sys-
tem; 
‘‘(3) identifies major programs and activities of 
the National Drug Control Program agencies that 
support the goals and annual objectives of the Na-
tional Drug Control Strategy; 
‘‘(4) evaluates the contribution of demand re-
duction and supply reduction activities implemented 
by each National Drug Control Program agency in 
support of the National Drug Control Strategy;
‘‘(5) monitors consistency of drug-related goals 
and objectives among the National Drug Control 
Program agencies and ensures that each agency’s 
goals, objectives, and budgets support and are fully 
consistent with the National Drug Control Strategy; 
and 
‘‘(6) coordinates the development and imple-
mentation of national drug control data collection 
and reporting systems to support policy formulation 
and performance measurement, including an assess-
ment of—
‘‘(A) the quality of current drug use meas-
urement instruments and techniques to measure 
supply reduction and demand reduction activi-
ties; 
‘‘(B) the adequacy of the coverage of exist-
ing national drug use measurement instruments 
and techniques to measure the illicit drug user 
population, and groups that are at risk for il-
licit drug use; and 
‘‘(C) the adequacy of the coverage of exist-
ing national treatment outcome monitoring sys-
tems to measure the effectiveness of drug abuse 
treatment in reducing illicit drug use and crimi-
nal behavior during and after the completion of 
substance abuse treatment; and 
‘‘(7) identifies the actions the Director shall 
take to correct any inadequacies, deficiencies, or lim-
itations identified in the assessment described in 
paragraph (6). 
‘‘(c) MODIFICATIONS.—A description of any modi-
fications made during the preceding year to the national 
drug performance measurement system described in sub-
section (b) shall be included in each report submitted 
under subsection (a).’’. 
SEC. 9. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM. 
Section 707 (21 U.S.C. 1706) is amended to read as 
follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.—
‘‘(1) IN GENERAL.—There is established in the 
Office a program to be known as the High Intensity 
Drug Trafficking Areas Program (in this section re-
ferred to as the ‘Program’). 
‘‘(2) PURPOSE.—The purpose of the Program 
is to reduce drug trafficking and drug production in 
the United States by—
‘‘(A) facilitating cooperation among Fed-
eral, State, and local law enforcement agencies 
to share information and implement coordinated 
enforcement activities; 
‘‘(B) enhancing intelligence sharing among 
Federal, State, and local law enforcement agen-
cies; 
‘‘(C) providing reliable intelligence to law 
enforcement agencies needed to design effective 
enforcement strategies and operations; and 
‘‘(D) supporting coordinated law enforce-
ment strategies which maximize use of available 
resources to reduce the supply of illegal drugs 
in designated areas and in the United States as 
a whole. 
‘‘(b) DESIGNATION.—The Director, upon consulta-
tion with the Attorney General, the Secretary of the 
Treasury, the Secretary of Homeland Security, heads of 
the National Drug Control Program agencies, and the 
Governor of each applicable State, may designate any 
specified area of the United States as a high intensity 
drug trafficking area. After making such a designation 
and in order to provide Federal assistance to the area so 
designated, the Director may—
‘‘(1) obligate such sums as are appropriated for 
the Program; 
‘‘(2) direct the temporary reassignment of Fed-
eral personnel to such area, subject to the approval 
of the head of the department or agency that em-
ploys such personnel; 
‘‘(3) take any other action authorized under 
section 704 to provide increased Federal assistance 
to those areas; and 
‘‘(4) coordinate activities under this section 
(specifically administrative, recordkeeping, and funds 
management activities) with State and local officials. 
‘‘(c) PETITIONS FOR DESIGNATION.—The Director 
shall establish regulations under which a coalition of inter-
ested law enforcement agencies from an area may petition 
for designation as a high intensity drug trafficking area. 
Such regulations shall provide for a regular review by the 
Director of the petition, including a recommendation re-
garding the merit of the petition to the Director by a panel 
of qualified, independent experts. 
‘‘(d) FACTORS FOR CONSIDERATION.—In considering 
whether to designate an area under this section as a high 
intensity drug trafficking area, the Director shall consider, 
in addition to such other criteria as the Director considers 
to be appropriate, the extent to which—
‘‘(1) the area is a significant center of illegal 
drug production, manufacturing, importation, or dis-
tribution; 
‘‘(2) State and local law enforcement agencies 
have committed resources to respond to the drug 
trafficking problem in the area, thereby indicating a 
determination to respond aggressively to the prob-
lem; 
‘‘(3) drug-related activities in the area are hav-
ing a significant harmful impact in the area, and in 
other areas of the country; and 
‘‘(4) a significant increase in allocation of Fed-
eral resources is necessary to respond adequately to 
drug-related activities in the area. 
‘‘(e) ORGANIZATION
OF HIGH INTENSITY DRUG 
TRAFFICKING AREAS.—
‘‘(1) EXECUTIVE
BOARD
AND
OFFICERS.—To 
be eligible for funds appropriated under this section, 
each high intensity drug trafficking area shall be 
governed by an Executive Board. The Executive 
Board shall designate a chairman, vice chairman, 
and any other officers to the Executive Board that 
it determines are necessary.
‘‘(2) RESPONSIBILITIES.—The Executive Board 
of a high intensity drug trafficking area shall be re-
sponsible for—
‘‘(A) providing direction and oversight in 
establishing and achieving the goals of the high 
intensity drug trafficking area; 
‘‘(B) managing the funds of the high in-
tensity drug trafficking area; 
‘‘(C) reviewing and approving all funding 
proposals consistent with the overall objective of 
the high intensity drug trafficking area; and 
‘‘(D) reviewing and approving all reports 
to the Director on the activities of the high in-
tensity drug trafficking area. 
‘‘(3) BOARD REPRESENTATION.—None of the 
funds appropriated under this section may be ex-
pended for any high intensity drug trafficking area, 
or for a partnership or region of a high intensity 
drug trafficking area, if that area’s, region’s or part-
nership’s Executive Board does not apportion an 
equal number of votes between representatives of 
participating Federal agencies and representatives of 
participating State and local agencies. Where it is 
impractical for a equal number of representatives of 
Federal agencies and State and local agencies to at-
tend a meeting of an Executive Board in person, the 
Executive Board may use a system of proxy votes or 
weighted votes to achieve the voting balance required 
by this paragraph. 
‘‘(4) NO
AGENCY
RELATIONSHIP.—The eligi-
bility requirements of this section are intended to 
ensure the responsible use of Federal funds. Nothing 
in this section is intended to create an agency rela-
tionship between individual high intensity drug traf-
ficking areas and the Federal Government. 
‘‘(f) USE OF FUNDS.—The Director shall ensure that 
no Federal funds appropriated for the Program are ex-
pended for the establishment or expansion of drug treat-
ment programs, and shall ensure that not more than five 
percent of the Federal funds appropriated for the Pro-
gram are expended for the establishment of drug preven-
tion programs. 
‘‘(g) COUNTERTERRORISM ACTIVITIES.—
‘‘(1) ASSISTANCE AUTHORIZED.—The Director 
may authorize use of resources available for the Pro-
gram to assist Federal, State, and local law enforce-
ment agencies in investigations and activities related 
to terrorism and prevention of terrorism, especially 
but not exclusively with respect to such investiga-
tions and activities that are also related to drug 
trafficking. 
‘‘(2) LIMITATION.—The Director shall ensure—
‘‘(A) that assistance provided under para-
graph (1) remains incidental to the purpose of 
the Program to reduce drug availability and 
carry out drug-related law enforcement activi-
ties; and 
‘‘(B) that significant resources of the Pro-
gram are not redirected to activities exclusively 
related to terrorism, except on a temporary 
basis under extraordinary circumstances, as de-
termined by the Director. 
‘‘(h) ROLE OF DRUG ENFORCEMENT ADMINISTRA-
TION.—The Director, in consultation with the Attorney 
General, shall ensure that a representative of the Drug 
Enforcement Administration is included in the Intelligence 
Support Center for each high intensity drug trafficking 
area. 
‘‘(i) ANNUAL HIDTA PROGRAM BUDGET SUBMIS-
SIONS.—As part of the documentation that supports the 
President’s annual budget request for the Office, the Di-
rector shall submit to Congress a budget justification that 
includes the following:
‘‘(1) The amount requested for each high inten-
sity drug trafficking area with supporting narrative 
descriptions and rationale for each request. 
‘‘(2) A detailed justification for each funding 
request that explains the reasons for the requested 
funding level, how such funding level was determined 
based on a current assessment of the drug traf-
ficking threat in each high intensity drug trafficking 
area, how such funding will ensure that the goals 
and objectives of each such area will be achieved, 
and how such funding supports the National Drug 
Control Strategy. 
‘‘(j) EMERGING THREAT RESPONSE FUND.—
‘‘(1) IN GENERAL.—Subject to the availability 
of appropriations, the Director may expend up to 10 
percent of the amounts appropriated under this sec-
tion on a discretionary basis, to respond to any 
emerging drug trafficking threat in an existing high 
intensity drug trafficking area, or to establish a new 
high intensity drug trafficking area or expand an ex-
isting high intensity drug trafficking area, in accord-
ance with the criteria established under paragraph 
(2).
‘‘(2) CONSIDERATION
OF
IMPACT.—In allo-
cating funds under this subsection, the Director 
shall consider—
‘‘(A) the impact of activities funded on re-
ducing overall drug traffic in the United States, 
or minimizing the probability that an emerging 
drug trafficking threat will spread to other 
areas of the United States; and 
‘‘(B) such other criteria as the Director 
considers appropriate. 
‘‘(k) EVALUATION.—
‘‘(1) INITIAL REPORT.—Not later than 90 days 
after the date of the enactment of this subsection, 
the Director shall, after consulting with the Execu-
tive Boards of each designated high intensity drug 
trafficking area, submit a report to Congress that 
describes, for each designated high intensity drug 
trafficking area—
‘‘(A) the specific purposes for the high in-
tensity drug trafficking area; 
‘‘(B) the specific long-term and short-term 
goals and objectives for the high intensity drug 
trafficking area; 
‘‘(C) the measurements that will be used to 
evaluate the performance of the high intensity
drug trafficking area in achieving the long-term 
and short-term goals; and 
‘‘(D) the reporting requirements needed to 
evaluate the performance of the high intensity 
drug trafficking area in achieving the long-term 
and short-term goals. 
‘‘(2) EVALUATION OF HIDTA PROGRAM AS PART 
OF NATIONAL DRUG CONTROL STRATEGY.—For each 
designated high intensity drug trafficking area, the 
Director shall submit, as part of the annual National 
Drug Control Strategy report, a report that—
‘‘(A) describes—
‘‘(i) the specific purposes for the high 
intensity drug trafficking area; and 
‘‘(ii) the specific long-term and short-
term goals and objectives for the high in-
tensity drug trafficking area; and 
‘‘(B) includes an evaluation of the per-
formance of the high intensity drug trafficking 
area in accomplishing the specific long-term 
and short-term goals and objectives identified 
under paragraph (1)(B). 
‘‘(l) ASSESSMENT OF DRUG ENFORCEMENT TASK 
FORCES
IN
HIGH
INTENSITY
DRUG
TRAFFICKING 
AREAS.—Not later than 180 days after the date of enact-
ment of this subsection, and as part of each subsequent 
annual National Drug Control Strategy report, the Direc-
tor shall submit to Congress a report—
‘‘(1) assessing the number and operation of all 
federally funded drug enforcement task forces within 
each high intensity drug trafficking area; and 
‘‘(2) describing—
‘‘(A) each Federal, State, and local drug 
enforcement task force operating in the high in-
tensity drug trafficking area; 
‘‘(B) how such task forces coordinate with 
each other, with any high intensity drug traf-
ficking area task force, and with investigations 
receiving funds from the Organized Crime and 
Drug Enforcement Task Force; 
‘‘(C) what steps, if any, each such task 
force takes to share information regarding drug 
trafficking and drug production with other fed-
erally funded drug enforcement task forces in 
the high intensity drug trafficking area; 
‘‘(D) the role of the high intensity drug 
trafficking area in coordinating the sharing of 
such information among task forces; 
‘‘(E) the nature and extent of cooperation 
by each Federal, State, and local participant in
ensuring that such information is shared among 
law enforcement agencies and with the high in-
tensity drug trafficking area; 
‘‘(F) the nature and extent to which infor-
mation sharing and enforcement activities are 
coordinated with joint terrorism task forces in 
the high intensity drug trafficking area; and 
‘‘(G) any recommendations for measures 
needed to ensure that task force resources are 
utilized efficiently and effectively to reduce the 
availability of illegal drugs in the high intensity 
drug trafficking areas. 
‘‘(m) ASSESSMENT OF INTELLIGENCE SHARING IN 
HIGH
INTENSITY
DRUG
TRAFFICKING
AREAS—PRO-
GRAM.—Not later than 180 days after the date of the en-
actment of this subsection, and as part of each subsequent 
annual National Drug Control Strategy report, the Direc-
tor, in consultation with the Director of National Intel-
ligence, shall submit to Congress a report—
‘‘(1) evaluating existing and planned intel-
ligence systems supported by each high intensity 
drug trafficking area, or utilized by task forces re-
ceiving any funding under the Program, including 
the extent to which such systems ensure access and 
availability of intelligence to Federal, State, and
local law enforcement agencies within the high inten-
sity drug trafficking area and outside of it; 
‘‘(2) the extent to which Federal, State, and 
local law enforcement agencies participating in each 
high intensity drug trafficking area are sharing in-
telligence information to assess current drug traf-
ficking threats and design appropriate enforcement 
strategies; and 
‘‘(3) the measures needed to improve effective 
sharing of information and intelligence regarding 
drug trafficking and drug production among Fed-
eral, State, and local law enforcement participating 
in a high intensity drug trafficking area, and be-
tween such agencies and similar agencies outside the 
high intensity drug trafficking area. 
‘‘(n) COORDINATION
OF INTELLIGENCE SHARING 
WITH ORGANIZED CRIME DRUG ENFORCEMENT TASK 
FORCE PROGRAM.—The Director, in consultation with the 
Attorney General, shall ensure that any drug enforcement 
intelligence obtained by the Intelligence Support Center 
for each high intensity drug trafficking area is shared, on 
a timely basis, with the drug intelligence fusion center op-
erated by the Organized Crime Drug Enforcement Task 
Force of the Department of Justice.
‘‘(o) USE OF FUNDS TO COMBAT METHAMPHET-
AMINE TRAFFICKING.—
‘‘(1) IN GENERAL.—
‘‘(A) REQUIREMENT.—The Director shall 
ensure that, of the amounts appropriated for a 
fiscal 
year 
for 
the 
Program, 
at 
least 
$15,000,000 is allocated to combat the traf-
ficking of methamphetamine in areas des-
ignated by the Director as high intensity drug 
trafficking areas. 
‘‘(B) ACTIVITIES.—In meeting the require-
ment in subparagraph (A), the Director shall 
transfer funds to appropriate Federal, State, 
and local governmental agencies for employing 
additional Federal law enforcement personnel, 
or facilitating the employment of additional 
State and local law enforcement personnel, in-
cluding agents, investigators, prosecutors, lab-
oratory technicians, chemists, investigative as-
sistants, and drug prevention specialists. 
‘‘(2) APPORTIONMENT OF FUNDS.—
‘‘(A) FACTORS IN APPORTIONMENT.—The 
Director shall apportion amounts allocated 
under paragraph (1) among areas designated by
the Director as high intensity drug trafficking 
areas based on the following factors: 
‘‘(i) The number of methamphetamine 
manufacturing facilities discovered by Fed-
eral, State, or local law enforcement offi-
cials in the area during the previous fiscal 
year. 
‘‘(ii) The number of methamphet-
amine prosecutions in Federal, State, or 
local courts in the area during the previous 
fiscal year. 
‘‘(iii) The number of methamphet-
amine arrests by Federal, State, or local 
law enforcement officials in the area dur-
ing the previous fiscal year. 
‘‘(iv) The amounts of methamphet-
amine or listed chemicals (as that term is 
defined in section 102(33) of the Con-
trolled 
Substances 
Act 
(21 
U.S.C. 
802(33)) seized by Federal, State, or local 
law enforcement officials in the area dur-
ing the previous fiscal year. 
‘‘(v) Intelligence and predictive data 
from the Drug Enforcement Administra-
tion showing patterns and trends in abuse,
trafficking, and transportation in meth-
amphetamine and listed chemicals (as that 
term is so defined). 
‘‘(B) CERTIFICATION.—Before the Direc-
tor apportions any funds under this paragraph 
to a high intensity drug trafficking area, the 
Director shall certify that the law enforcement 
entities responsible for clandestine methamphet-
amine laboratory seizures in that area are pro-
viding laboratory seizure data to the national 
clandestine laboratory database at the El Paso 
Intelligence Center. 
‘‘(p) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to the Office of National 
Drug Control Policy to carry out this section—
‘‘(1) $280,000,000 for fiscal year 2007; 
‘‘(2) $290,000,000 for each of fiscal years 2008 
and 2009; and 
‘‘(3) $300,000,000 for each of fiscal years 2010 
and 2011.’’. 
SEC. 10. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS. 
(a) SHORT TITLE.—This section may be cited as the 
‘‘Dawson Family Community Protection Act’’. 
(b) FINDINGS.—Congress finds the following:
(1) In the early morning hours of October 16, 
2002, the home of Carnell and Angela Dawson was 
firebombed 
in 
apparent 
retaliation 
for 
Mrs. 
Dawson’s notification of police about persistent drug 
distribution activity in their East Baltimore City 
neighborhood. 
(2) The arson claimed the lives of Mr. and Mrs. 
Dawson and their 5 young children, aged 9 to 14. 
(3) The horrific murder of the Dawson family 
is a stark example of domestic narco-terrorism. 
(4) In all phases of counter-narcotics law en-
forcement—from prevention to investigation to pros-
ecution to reentry—the voluntary cooperation of or-
dinary citizens is a critical component. 
(5) Voluntary cooperation is difficult for law en-
forcement officials to obtain when citizens feel that 
cooperation carries the risk of violent retaliation by 
illegal drug trafficking organizations and their affili-
ates. 
(6) Public confidence that law enforcement is 
doing all it can to make communities safe is a pre-
requisite for voluntary cooperation among people 
who may be subject to intimidation or reprisal (or 
both).
(7) Witness protection programs are insufficient 
on their own to provide security because many indi-
viduals and families who strive every day to make 
distressed neighborhoods livable for their children, 
other relatives, and neighbors will resist or refuse of-
fers of relocation by local, State, and Federal pros-
ecutorial agencies and because, moreover, the contin-
ued presence of strong individuals and families is 
critical to preserving and strengthening the social 
fabric in such communities. 
(8) Where (as in certain sections of Baltimore 
City) interstate trafficking of illegal drugs has severe 
ancillary local consequences within areas designated 
as high intensity drug trafficking areas, it is impor-
tant that supplementary High Intensity Drug Traf-
ficking Areas Program funds be committed to sup-
port initiatives aimed at making the affected com-
munities safe for the residents of those communities 
and encouraging their cooperation with local, State, 
and Federal law enforcement efforts to combat ille-
gal drug trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS.—Section 707 (21 U.S.C. 1706), as 
amended by section 9, is further amended by adding at 
the end the following new subsection: